Barry W. Ritz, PhD, is the Chief Scientific Officer and VP, Professional R&D and Regulatory Affairs for Atrium Innovations, a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based dietary supplements for health care professionals and their patients. Atrium Innovations was acquired by Nestle Health Science in 2018. Dr. Ritz is highly engaged in the dietary supplement industry and serves as Chair-Elect on the Board of the Council for Responsible Nutrition. His background is in nutritional immunology, studying the influence of age and nutritional status on the innate immune response. Dr. Ritz has presented his research at national and international meetings and has numerous publications in scientific journals and texts. Atrium Innovations is highly invested in nutrition science research and partners with top universities. In 2016, received the prestigious NBJ Award for Achievement in Science and Innovation.